About: Neurizon Therapeutics Limited, a clinical stage biotechnology company, engages in the development of treatments for neurodegenerative diseases in Australia. Its lead candidate is NUZ-001, a small molecule drug designed to support cellular protein homeostasis which is evaluated in Regimen I of the Phase 2/3 HEALEY ALS platform trial for amyotrophic lateral sclerosis (ALS) and other neurodegenerative diseases. The company was formerly known as PharmAust Limited and changed its name to Neurizon Therapeutics Limited in October 2024. Neurizon Therapeutics Limited was incorporated in 2000 and is based in Melbourne, Australia.
Sector: Healthcare
Industry: Biotechnology
Latest price: A$0.09 (+3.57%)
NUZ ASX Neurizon Therapeutics Ltd
Neurizon Therapeutics Ltd share price
NUZ price activity
Último preço
$ 0,090
Variação (24h)
0,00 AUD (3,57%)
Volume
1.48M
Volume (média 4 sem.)
-
Abertura
$ 0,08
Variação do dia
$ 0,08 - $ 0,10
Fechamento anterior
$ 0,08
Último negócio
06 Oct, 5:10 am GMT+0
Atrasado
06 Oct, 5:10 am GMT+0
NUZ price performance
Atrasado
06 Oct, 5:10 am GMT+0
quote.marketSignals